IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization.

Cytokines play an important role in modulating inflammatory responses and, as a result, airway tone. IL-10 is a regulatory cytokine that has been suggested for treatment of asthma because of its immunosuppressive and anti-inflammatory properties. In contrast to these suggestions, we demonstrate in a model of allergic sensitization that mice deficient in IL-10 (IL-10-/-) develop a pulmonary inflammatory response but fail to exhibit airway hyperresponsiveness in both in vitro and in vivo assessments of lung function. Reconstitution of these deficient mice with the IL-10 gene fully restores development of airway hyperresponsiveness comparable to control mice. These results identify an important role of IL-10, downstream of the inflammatory cascade, in regulating the tone of the airways after allergic sensitization and challenge.

[1]  M. Grunstein,et al.  Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. , 1999, The Journal of clinical investigation.

[2]  E. Hamelmann,et al.  Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. , 1999, American journal of respiratory and critical care medicine.

[3]  F. Saulnier,et al.  Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. , 1999, American journal of respiratory and critical care medicine.

[4]  M. Wills-Karp.  Immunologic basis of antigen-induced airway hyperresponsiveness. , 1999, Annual review of immunology.

[5]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[6]  J. Wijdenes,et al.  Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation. , 1998, Cytokine.

[7]  P. Bongrand,et al.  Alveolar macrophage interleukin (IL)‐10 and IL‐12 production in atopic asthma , 1998, Allergy.

[8]  L. Borish,et al.  IL-10: evolving concepts. , 1998, The Journal of allergy and clinical immunology.

[9]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[10]  E. Gelfand,et al.  Development of Eosinophilic Airway Inflammation and Airway Hyperresponsiveness in Mast Cell–deficient Mice , 1997, The Journal of experimental medicine.

[11]  E. Gelfand,et al.  Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. , 1997, American journal of respiratory cell and molecular biology.

[12]  M. Goldman,et al.  IL-10: a potential therapy for allergic inflammation? , 1997, Immunology today.

[13]  E. Gelfand,et al.  T lymphocytes: Setting the tone of the airways , 1997, Nature Medicine.

[14]  N. Davidson,et al.  Studies with IL‐10‐/‐ mice: an overview , 1997, Journal of leukocyte biology.

[15]  E. Gelfand,et al.  Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. , 1997, American journal of respiratory and critical care medicine.

[16]  M. Jordana,et al.  Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia , 1997, Gene Therapy.

[17]  E. Gelfand,et al.  Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. , 1996, The Journal of clinical investigation.

[18]  S. Durham,et al.  Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. , 1996, American journal of respiratory cell and molecular biology.

[19]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[20]  D. Leduc,et al.  Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. , 1995, The Journal of clinical investigation.

[21]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[22]  E. Gelfand,et al.  Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. , 1992, The Journal of clinical investigation.

[23]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.